carcinogens - CISMeF

Preferred Label : carcinogens;

MeSH definition : Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included.;

MeSH synonym : oncogens; Carcinogen; Oncogen;

MeSH hyponym : tumor initiators; tumor promoters; Initiators, Tumor; Promoters, Tumor; Tumor Initiator; Initiator, Tumor; Tumor Promoter; Promoter, Tumor;

MeSH annotation : Manual 24.5.6.2 ;

Wikipedia link : https://en.wikipedia.org/wiki/Carcinogen;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D002273;

UMLS CUI

C0007090;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- toxicity [MeSH Qualifier]
Currated CISMeF NLP mapping
- Carcinogen [NCIt concept]
- Carcinogen (substance) [SNOMED CT concept]
- carcinogen, nos [SNOMED Notion]
Indexing information
- 2-hydroxy-4-glutathion-S-yl-17 beta-estradiol [MeSH Supplementary Concept]
- Limonene [MeSH Descriptor]
- N-(2-methoxyphenyl)hydroxylamine [MeSH Supplementary Concept]
- N-nitrosodihydrouracil [MeSH Supplementary Concept]
- ag 243-5 protein, mycoplasma arginini [MeSH Supplementary Concept]
Metaterm(s)
- oncology [CISMeF Metaterm]
Record concept(s)
- carcinogens [MeSH concept]
- tumor initiators [MeSH concept]
- tumor promoters [MeSH concept]
See also
- Disinfection By-Products [DeCS]
- Genotoxicity [DeCS]
- anticarcinogenic agents [MeSH Descriptor]
- benzidines [MeSH Descriptor]
- cocarcinogenesis [MeSH Descriptor]
- mutagens [MeSH Descriptor]
- neoplasms [MeSH Descriptor]
- oncogenic viruses [MeSH Descriptor]
See also (suggested by CISMeF)
- carcinogenicity tests [MeSH Descriptor]
See also inter- (CISMeF)
- Tumor Promoter [NCIt concept]
- carcinogen effect, nos [SNOMED Notion]
Semantic type(s)
- Hazardous or Poisonous Substance [UMLS semantic type]
Substance(s)
- 1,2,5,6-dibenzanthracene [MeSH Supplementary Concept]
- 1,2-Dimethylhydrazine [MeSH Descriptor]
- 1,2-diamino-4-nitrobenzene [MeSH Supplementary Concept]
- 1,2-dihydroxy-epoxy-1,2,3,4-tetrahydro-5-methylchrysene [MeSH Supplementary Concept]
- 1,2-epoxy-3,4-dihydroxy-1,2,3,4-tetrahydrobenzo(c)phenanthrene [MeSH Supplementary Concept]
- 1,3-butadiene [MeSH Supplementary Concept]
- 1,3-dinitropyrene [MeSH Supplementary Concept]
- 1,8-dinitropyrene [MeSH Supplementary Concept]
- 1-Naphthylamine [MeSH Descriptor]
- 1-hydroxyanthraquinone [MeSH Supplementary Concept]
- 1-nitronaphthalene [MeSH Supplementary Concept]
- 1-phenylazo-2-naphthol [MeSH Supplementary Concept]
- 2',3-dimethyl-4-aminobiphenyl [MeSH Supplementary Concept]
- 2,2-bis(4-glycidyloxyphenyl)propane [MeSH Supplementary Concept]
- 2,4-diaminotoluene [MeSH Supplementary Concept]
- 2,4-dinitrotoluene [MeSH Supplementary Concept]
- 2,6-diaminotoluene [MeSH Supplementary Concept]
- 2-Acetylaminofluorene [MeSH Descriptor]
- 2-Naphthylamine [MeSH Descriptor]
- 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine [MeSH Supplementary Concept]
- 2-amino-3,4-dimethylimidazo(4,5-f)quinoline [MeSH Supplementary Concept]
- 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline [MeSH Supplementary Concept]
- 2-amino-3-methylimidazo(4,5-f)quinoline [MeSH Supplementary Concept]
- 2-aminofluorene [MeSH Supplementary Concept]
- 2-anthramine [MeSH Supplementary Concept]
- 2-cyanoethylene oxide [MeSH Supplementary Concept]
- 2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine [MeSH Supplementary Concept]
- 2-nitro-7-methoxynaphtho(2-1b)furan [MeSH Supplementary Concept]
- 2-nitrosofluorene [MeSH Supplementary Concept]
- 2-phenylphenol [MeSH Supplementary Concept]
- 2-toluidine [MeSH Supplementary Concept]
- 3,3'-Dichlorobenzidine [MeSH Descriptor]
- 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine [MeSH Supplementary Concept]
- 3-amino-1-methyl-5H-pyrido(4,3-b)indole [MeSH Supplementary Concept]
- 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone [MeSH Supplementary Concept]
- 3-nitrofluoranthene [MeSH Supplementary Concept]
- 4,4'-diaminodiphenylmethane [MeSH Supplementary Concept]
- 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone [MeSH Supplementary Concept]
- 4-(methylnitrosoamino)-4-(3-pyridyl)-1-butanol [MeSH Supplementary Concept]
- 4-Hydroxyaminoquinoline-1-oxide [MeSH Descriptor]
- 4-acetylaminofluorene [MeSH Supplementary Concept]
- 4-acetylaminostilbene [MeSH Supplementary Concept]
- 4-biphenylamine [MeSH Supplementary Concept]
- 4-chloromethylbiphenyl [MeSH Supplementary Concept]
- 4-dichlorobenzene [MeSH Supplementary Concept]
- 4-hydroxymethylbiphenyl [MeSH Supplementary Concept]
- 4-hydroxyphenylacetic acid [MeSH Supplementary Concept]
- 4-methylcatechol [MeSH Supplementary Concept]
- 4-nitroquinoline-1-oxide [MeSH Descriptor]
- 4-vinyl-1-cyclohexene dioxide [MeSH Supplementary Concept]
- 5-methylchrysene [MeSH Supplementary Concept]
- 6-nitrobenzo(a)pyrene [MeSH Supplementary Concept]
- 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide [MeSH Descriptor]
- 7-methylbenzanthracene [MeSH Supplementary Concept]
- 7H-dibenzo(c,g)carbazole [MeSH Supplementary Concept]
- 9,10-Dimethyl-1,2-benzanthracene [MeSH Descriptor]
- ANFT [MeSH Supplementary Concept]
- ENNG [MeSH Supplementary Concept]
- Glu-P-2 [MeSH Supplementary Concept]
- N'-nitrosonornicotine [MeSH Supplementary Concept]
- N,N'-dinitrosopiperazine [MeSH Supplementary Concept]
- N-(deoxyguanosin-8-yl)-2-aminofluorene [MeSH Supplementary Concept]
- N-amyl-N-methylnitrosamine [MeSH Supplementary Concept]
- N-ethyl-N-hydroxyethylnitrosamine [MeSH Supplementary Concept]
- N-hydroxy-2-aminofluorene [MeSH Supplementary Concept]
- N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine [MeSH Supplementary Concept]
- N-nitroso(di-n-propyl)amine [MeSH Supplementary Concept]
- N-nitroso-2,6-dimethylmorpholine [MeSH Supplementary Concept]
- N-nitrosobutylurea [MeSH Supplementary Concept]
- N-nitrosodiethanolamine [MeSH Supplementary Concept]
- N-nitrosodiphenylamine [MeSH Supplementary Concept]
- N-nitrosomorpholine [MeSH Supplementary Concept]
- N-nitrosopiperidine [MeSH Supplementary Concept]
- N-phenyl-1-naphthylamine [MeSH Supplementary Concept]
- acetylhydrazine [MeSH Supplementary Concept]
- acrylonitrile [MeSH Descriptor]
- aflatoxicol [MeSH Supplementary Concept]
- aflatoxin B1-2,3-oxide [MeSH Supplementary Concept]
- alpha-hexachlorocyclohexane [MeSH Supplementary Concept]
- aniline [MeSH Supplementary Concept]
- aristolochic acid I [MeSH Supplementary Concept]
- asarone [MeSH Supplementary Concept]
- asbestos [MeSH Descriptor]
- azoxymethane [MeSH Descriptor]
- benzo(a)pyrene 4,5-epoxide [MeSH Supplementary Concept]
- bromodichloromethane [MeSH Supplementary Concept]
- bromoform [MeSH Supplementary Concept]
- butachlor [MeSH Supplementary Concept]
- butyl(3-carboxypropyl)nitrosamine [MeSH Supplementary Concept]
- butylated hydroxyanisole [MeSH Descriptor]
- calyculin A [MeSH Supplementary Concept]
- carbadox [MeSH Descriptor]
- carbamylhydrazine [MeSH Supplementary Concept]
- carbazole [MeSH Supplementary Concept]
- chlorozotocin [MeSH Supplementary Concept]
- chrysarobin [MeSH Supplementary Concept]
- cycasin [MeSH Descriptor]
- cyclopenta(c,d)pyrene [MeSH Supplementary Concept]
- debromoaplysiatoxin [MeSH Supplementary Concept]
- dehydroretronecine [MeSH Supplementary Concept]
- dibenzacridine [MeSH Supplementary Concept]
- dibenzo(a,l)pyrene [MeSH Supplementary Concept]
- dibutylnitrosamine [MeSH Supplementary Concept]
- diepoxybutane [MeSH Supplementary Concept]
- diethylstilbestrol [MeSH Descriptor]
- dihydroteleocidin B [MeSH Supplementary Concept]
- diisopropanolnitrosamine [MeSH Supplementary Concept]
- dimethylhydrazines [MeSH Descriptor]
- dipin [MeSH Supplementary Concept]
- direct black 3 [MeSH Supplementary Concept]
- ethyl acrylate [MeSH Supplementary Concept]
- ferric nitrilotriacetate [MeSH Supplementary Concept]
- fluorene [MeSH Supplementary Concept]
- glycidol [MeSH Supplementary Concept]
- hydrazine [MeSH Supplementary Concept]
- indolactam V [MeSH Supplementary Concept]
- methyl tert-butyl ether [MeSH Supplementary Concept]
- methyl(acetoxymethyl)nitrosamine [MeSH Supplementary Concept]
- methylazoxymethanol [MeSH Supplementary Concept]
- methyleugenol [MeSH Supplementary Concept]
- mezerein [MeSH Supplementary Concept]
- microcystins [MeSH Descriptor]
- n-dodecane [MeSH Supplementary Concept]
- nickel subsulfide [MeSH Supplementary Concept]
- nitrosobenzylmethylamine [MeSH Supplementary Concept]
- nitrosobis(2-oxopropyl)amine [MeSH Supplementary Concept]
- ochratoxin A [MeSH Supplementary Concept]
- okadaic acid [MeSH Descriptor]
- p-dimethylaminoazobenzene [MeSH Descriptor]
- phenethyl isothiocyanate [MeSH Supplementary Concept]
- phorbol 12,13-Dibutyrate [MeSH Descriptor]
- phorbol esters [MeSH Descriptor]
- phorbol-12,13-didecanoate [MeSH Supplementary Concept]
- potassium bromate [MeSH Supplementary Concept]
- pristane [MeSH Supplementary Concept]
- propylene oxide [MeSH Supplementary Concept]
- propylnitrosourea [MeSH Supplementary Concept]
- ptaquiloside [MeSH Supplementary Concept]
- sodium nitrate [MeSH Supplementary Concept]
- styrene oxide [MeSH Supplementary Concept]
- teleocidins [MeSH Supplementary Concept]
- tetrachloroethylene [MeSH Descriptor]
- tetradecanoylphorbol acetate [MeSH Descriptor]
- thorium dioxide [MeSH Descriptor]
- urethane [MeSH Descriptor]
- vinyl chloride [MeSH Descriptor]
- vinyl fluoride [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Carcinogen [NCIt concept]
- Carcinogen (substance) [SNOMED CT concept]
- Chemical Carcinogen [NCIt concept]
- carcinogen, nos [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients